Bystander virus infection prolongs activated T cell survival

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4527-4535

  Mitchell, Tom ^a   Kappler, John ^a,b   Marrack, Philippa ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERANTIGEN;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL DEATH; CELL KILLING; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD95; BCL-X PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; ENTEROTOXINS; FEMALE; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS; TIME FACTORS; TRANSCRIPTION, GENETIC; VACCINIA;

EID: 0033561753     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Vella, A. T., J. E. McCormack, P. S. Linsley, J. W. Kappler, and P. Marrack. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:1.
2. Khoruts, A., A. Mondino, K. A. Pape, S. L. Reiner, and M. K. Jenkins. 1998. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187: 225.
3. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
4. + T cells. J. Immunol. 159:591.
5. Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54:1.
6. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:4.
7. McCormack, J. E., J. E. Callahan, J. Kappler, and P. Marrack. 1993. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J. Immunol 150:3785.
8. Vella, A. T., S. Dow, T. A. Potter, J. Kappler, and P. Marrack. 1998. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95:3810.
9. Vella, A. T., T. Mitchell, B. Groft, P. S. Linsley, J. M. Green, C. B. Thompson, J. W. Kappler, and P. Marrack. 1997. CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. J. Immunol. 158:4714.
10. Jenner, E. 1798. An inquiry into the causes and effects of the variolae vaccinae.
11. Panicali, D., S. W. Davis, R. L. Weinberg, and E. Paoletti. 1983. Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 80:5364.
12. Smith, G. L., M. Mackett, and B. Moss. 1983. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302:490.
13. Carpenter, E. A., J. Ruby, and I. A. Ramshaw. 1994. IFN-[gamma], TNF, and IL-6 production by vaccinia virus immune spleen cells: an in vitro study. J. Immunol. 152:2652.
14. Ruby, J., L. Sedger, and I. Ramshaw. 1993. Cytokine production in virus-infected mice: a single cell analysis. Viral Immunol. 6:125.
15. Buller, R. M. L., G. L. Smmith, K. Cremer, N. A. L, and B. Moss. 1985. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 317:813.
16. Fields, B. N., and D. M. Knipe. 1990 Virology. In Poxviridae: The Viruses and Their Replication, Vol. 2. B. Moss, ed. Raven Press, New York. p. 2637.
17. Earl, P., N. Cooper, and B. Moss. 1991. Preparation of cell cultures and vaccinia virus stocks. Curr. Protocols Mol. Biol. 2:16.16.2.
18. +)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
19. O'Brien, M. C., and W. E. Bolton. 1995. Comparison of cell viability probes compatible with fixation and permeabilization for combined surface and intra-cellular staining in flow cytometry. Cytometry 19:243.
20. Veis, D. J., C. L. Sentman, E. A. Bach, and S. J. Korsmeyer. 1993. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151:2546.
21. Boise, L. H., A. J. Minn, P. J. Noel, C. H. June, M. A. Accavitti, T. Lindsten, and C. B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:87.
22. Lucas, P. J., I. Negishi, K. Nakayama, L. E. Fields, and D. Y. Loh. 1995. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:5757.
23. Noel, P. J., L. H. Boise, J. M. Green, and C. B. Thompson. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636.
24. Sperling, A. I., J. A. Auger, B. D. Ehst, I. C. Rulifson, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 157:3909.
25. + helper T cells: a model for the long-term survival of memory cells. J. Immunol. 156:1764.
26. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245.
27. Weston, S. A., and C. R. Parish. 1990. New fluorescent dyes for lymphocyte migration studies: analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods 133:87.
28. Kuroda, K., J. Yagi, K. Imanishi, X. Yan, X. Li, W. Fujimaki, H. Kato, T. Miyoshi-Akiyama, Y. Kumazawa, H. Abe, and T. Uchiyama. 1996. Implantation of IL-2 containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen. J. Immunol. 157:1422.
29. Belfrage, H., M. Dohlsten, G. Hedlund, and T. Kalland. 1997. Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment. Cancer Immunol. Immunother. 44:77.
30. Belfrage, H., M. Dohlsten, G. Hedlund, and T. Kalland. 1997. Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxicity by IL-2 in vivo. Immunology 90:183.
31. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918.
32. Vella, A., T. K. Teague, J. Ihle, J. Kappler, and P. Marrack. 1997. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186:325.
33. Akbar, A. N., N. J. Borthwick, R. G. Wickremasinghe, P. Panayoitidis, D. Pilling, M. Bofill, S. Krajewski, J. C. Reed, and M. Salmon. 1996. Interleukin-2 receptor common γ-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol 26:294.
34. + T cells to cause immunopathology. J. Exp. Med. 187:763.
35. Aoki, Y., K. Hiromatsu, J. Usami, M. Makino, H. Igarashi, J. Ogasawara, S. Nagata, and Y. Yoshikai. 1994. Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retroviral infection. J. Immunol. 153:3611.
36. Rocken, M., J. F. Urban, and E. M. Shevach. 1992. Infection breaks T-cell tolerance. Nature 359:79.
37. Horwitz, M. S., L. M. Bradley, J. Harbertson, T. Krahl, J. Lee, and N. Sarvetnick. 1998. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4:781.
38. Zhao, Z. S., F. Granucci, L. Yeh, P. A. Schaffer, and H. Cantor. 1998. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279:1344.
39. Singer, G. G., and A. K. Abbas. 1994. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
40. Van Parijs, L., and A. K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280:243.
41. Miethke, T., R. Vabulas, R. Bittlingmaier, K. Heeg, and H. Wagner. 1996. Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation-associated apoptosis. Eur. J. Immunol. 26:1459.
42. Tucek-Szabo, C. L., S. Andjelic, E. Lacy, K. B. Elkon, and J. Nikolic-Zugic. 1996. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis: activation-induced death can occur without Fas receptor. J. Immunol. 156: 192.
43. Scott, D. E., W. J. Kisch, and A. D. Steinberg. 1993. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupusprone mice. J. Immunol. 150:664.
44. Mogil, R. J., L. Radvanyi, R. Gonzalez-Quintial, R. Miller, G. Mills, A. N. Theofilopoulos, and D. R. Green. 1995. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int. Immunol. 7:1451.
45. Van Parijs, L., D. A. Peterson, and A. K. Abbas. 1998. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8:265.
46. Gonzalo, J. A., A. Gonzalez-Garcia, C. Martinez, and G. Kroemer. 1993. Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo. J. Exp. Med 177:1239.
47. Munn, D. H., J. Pressey, A. C. Beall, R. Hudes, and M. R. Alderson. 1996. Selective activation-induced apoptosis of peripheral T cells imposed by macrophages: a potential mechanism of antigen-specific peripheral lymphocyte deletion. J. Immunol. 156:523.
48. Wesch, D., S. Marx, and D. Kabelitz. 1998. Monocyte-dependent death of freshly isolated T lymphocytes: induction by phorbolester and mitogens and differential effects of catalase. J. Immunol. 161:1248.